MTOR and breast cancer: Recently, Zhao et al. demonstrated that DEPDC1 overexpression led to a significant promotion of proliferation by regulating the cell cycle in breast cancer, and that DEPDC1 was associated with a high activation of the PI3K-AKT-mTOR signaling pathway [35].